Clinical Trials Directory

Trials / Completed

CompletedNCT04920123

Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic

Towards the Development of a Mobile-health Technology Designed to Encourage the Use of Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
University of Massachusetts, Amherst · Academic / Other
Sex
All
Age
55 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate the therapeutic efficacy of Neuro-World cognitive training games (Woorisoft, S. Korea) in patients with mild cognitive impairment.

Detailed description

This study will be a cross-over randomized controlled trial. Fifty participants will be enrolled and randomly assigned to group A or group B. Group A will self-administer Neuro-World cognitive training games for 30 minutes a day, twice a week for 12 weeks in the home setting (i.e., intervention period). For the following 12 weeks, the participants will not engage in any therapist-supervised cognitive therapies (i.e., no-intervention period). Group B will not engage in any therapist-supervised cognitive therapies (i.e., no-intervention period). For the following 12 weeks, the participants will self-administer Neuro-World cognitive training games for 30 minutes a day, twice a week in the home setting (i.e., intervention period). All the participants in both groups will receive phone calls twice a week to 1) provide feedback on their adherence to Neuro-World cognitive training (during the intervention period) and 2) learn any significant changes in the level of their daily activities (during the no-intervention period and the intervention period).

Conditions

Interventions

TypeNameDescription
DEVICENeuro-WorldNeuro-World is a collection of six games that are developed for cognitive training that focuses on memory and attention.

Timeline

Start date
2022-02-17
Primary completion
2025-03-31
Completion
2025-03-31
First posted
2021-06-09
Last updated
2025-08-07
Results posted
2025-08-07

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04920123. Inclusion in this directory is not an endorsement.